Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL590699 | 0.95 | LMNA (0.71) | LMNAALDH1A1HSD17B10THRBTSHR | |
| Butanone SCHEMBL9440666 | 0.90 | LMNA (0.57) | LMNAALDH1A1HSD17B10THRBTSHR | |
| Acetone SCHEMBL1036956 | 0.90 | LMNA (0.63) | LMNAALDH1A1HSD17B10THRBTSHR | |
| Acetone SCHEMBL16666366 | 0.87 | LMNA (0.60) | LMNAALDH1A1HSD17B10THRBTSHR | |
| Acetic Acid SCHEMBL23907968 | 0.86 | LMNA (0.67) | LMNAALDH1A1HSD17B10THRBTSHR | |
| Butanedione SCHEMBL4368674 | 0.86 | LMNA (0.67) | LMNAALDH1A1HSD17B10THRBTSHR | |
| Acetic Acid SCHEMBL222953 | 0.86 | LMNA (0.67) | LMNAALDH1A1HSD17B10THRBTSHR | |
| Ethylene SCHEMBL11548600 | 0.86 | LMNA (0.52) | LMNAALDH1A1HSD17B10THRBTDP1 | |
| Ethylene SCHEMBL4935788 | 0.86 | LMNA (0.75) | LMNATHRB | |
| Ethylene SCHEMBL555416 | 0.86 | LMNA (0.86) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109293472-A | A kind of method that alkynol prepares enol through partial hydrogenation | 万华化学集团股份有限公司 | 2019-02-01 | — | — | CN | claimed |
| CN-109293472-A | A kind of method that alkynol prepares enol through partial hydrogenation | 万华化学集团股份有限公司 | 2019-02-01 | — | — | CN | disclosed |
| EP-1686114-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-10-07 | — | — | EP | disclosed |
| US-20090030210-A1 | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-01-29 | — | — | US | disclosed |
| US-7470525-B2 | Process for producing optically active 2-alkycysteine, derivative thereof, and processes for production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-20070037260-A1 | allowing cells of microorganism or treated products thereof having an activity of stereoselective hydrolysis of the amide bond of a 2-alkyl-L-cysteinamide or a salt thereof to act on a 2-alkylcysteinamide consisting of a mixture of D- and L-isomers or a salt thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-02-15 | — | — | US | disclosed |
| EP-1686114-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030210-A1 | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | AADAT, CBS, CTH | LMNA 4238/4885ALDH1A1 444/4885HSD17B10 1592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.